Similar Papers

Paper Title
Journal
Date
Author
Randomized phase II trial of lymphodepletion plus adoptive cell transfer of tumor-infiltrating lymphocytes, with or without dendritic cell vaccination, in patients with metastatic melanoma
Chantal Saberian ... Chantale Bernatchez
Journal for ImmunoTherapy of Cancer | VOL. 9
Chantal Saberian, et. al.Chantal Saberian ... Chantale Bernatchez
01 May 2021
440 Utilizing Stim-RTM technology to reduce live feeder cells in the tumor infiltrating lymphocyte culture process
Riley P Allen ... Mikayla Min
Journal for ImmunoTherapy of Cancer | VOL. 12
Riley P Allen, et. al.Riley P Allen ... Mikayla Min
01 Nov 2024
Breast Cancers Are Immunogenic: Immunologic Analyses and a Phase II Pilot Clinical Trial Using Mutation-Reactive Autologous Lymphocytes.
...
Journal of Clinical Oncology | VOL. 40
, et. al. ...
01 Feb 2022
465 Generation of tumor-reactive T cell-enriched tumor infiltrating lymphocytes(TILs) product with autologous patient-derived organoid(PDO)
Zhenjiang Liu ... Yarong Liu
Journal for ImmunoTherapy of Cancer | VOL. 12
Zhenjiang Liu, et. al.Zhenjiang Liu ... Yarong Liu
01 Nov 2024
View more papers

More From: Journal for ImmunoTherapy of Cancer

Paper Title
Journal
Date
Author
Combination of a therapeutic cancer vaccine targeting the endogenous retroviral envelope protein ERVMER34-1 with immune-oncology agents facilitates expansion of neoepitope-specific T cells and promotes tumor control.
Maria Del Mar Maldonado ... Duane H Hamilton
Journal for immunotherapy of cancer | VOL. 13
Maria Del Mar Maldonado, et. al.Maria Del Mar Maldonado ... Duane H Hamilton
13 May 2025
Regional distribution of HLA frequencies in the USA: implications for TCR-based therapies.
Christian Roy ... Dirk Nagorsen
Journal for immunotherapy of cancer | VOL. 13
Christian Roy, et. al.Christian Roy ... Dirk Nagorsen
13 May 2025
Asia's emergence in cancer immunotherapy: challenges and opportunities.
Yan Li ... Cheng Sun
Journal for immunotherapy of cancer | VOL. 13
Yan Li, et. al.Yan Li ... Cheng Sun
13 May 2025
GP73: the key to unlocking immunotherapies efficacy in solid tumors?
Rebecca J Bayliss ... Alan L Parker
Journal for immunotherapy of cancer | VOL. 13
Rebecca J Bayliss, et. al.Rebecca J Bayliss ... Alan L Parker
13 May 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.